2023

Zinzani, PL, Mayer, J, Flowers, CR, Bijou, F, De Oliveira, AC, Song, YQ, Zhang, QY, Merli, M, Bouabdallah, K, Ganly, P, Zhang, HL, Johnson, R, Garcia-Sancho, AM, Pulla, MP, Trneny, M, Yuen, S, Tilly, H, Kingsley, E, Tumyan, G, Assouline, SE, Auer, R, Ivanova, E, Kim, P, Huang, S, Delarue, R, Trotman, J. ROSEWOOD: A Phase II Randomized Study of Zanubrutinib Plus Obinutuzumab Versus Obinutuzumab Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma. J CLIN ONCOL 41 5107-. 20 nov 2023. . . F.I.:45,400 [doi:10.1200/JCO.23.00775]

Nastoupil, Loretta J., Dahiya, Saurabh, Palomba, M. Lia, Martin Garcia-Sancho, Alejandro, Reguera Ortega, Juan Luis, Kuruvilla, John, Jager, Ulrich, Cartron, Guillaume, Izutsu, Koji Izutsu, Dreyling, Martin, Kahl, Brad, Ghesquieres, Herve, Ardeshna, Kirit, Goto, Hideki, Barbui, Anna Maria, Abramson, Jeremy S., Borchmann, Peter, Fleury, Isabelle, Mielke, Stephan, Farazi, Thalia, Fasan, Omotayo, Lymp, James, Vedal, Min, Nishii, Rina, Avilion, Ariel, Papuga, Jessica, Morschhauser, Frank. TRANSCEND FL: Phase II Study Results of Lisocabtagene Maraleucel (Liso-Cel) in Patients With R/R Follicular Lymphoma (FL). CL LYMPH MYELOM LEUK 23 447-448. 1 sep 2023. . . F.I.:2,700 
Alonso, David, Navarro, Almudena, Alejo, Elena, Garcia, Maria, Antonio Queizan, Jose, Cabero, Almudena, Eugenia Alonso, Maria, Garcia-Bacelar, Ana, Davila, Julio, Labrador, Jorge, Fernandez, Silvia, Albarran, Beatriz, Aguilar, Carlos, Pardal, Emilia, De Cabo, Erick, Jesus Penarrubia, Maria, Cidoncha, Borja, Martinez, Gerardo, Villaescusa, Teresa, Maria Navarro, Jose, Patricia Gomez, Sandra, Puerta, Carlos, Garcia-Jaen, Pablo, Gabriela Zapata, Evelyn, Clavo, Diego, Jose Malaver, Rafael, Teresa Fuentes, Cristina, Fernandez, Adolfo, Santos, Carmen, Martin, Alejandro, Alcoceba, Miguel, Norma Gutierrez, Carmen. 17P (TP53) Deletion Determines Worse Survival in Diffuse Large B-Cell Lymphoma Patients After First-Line Treatment With Immunochemotherapy: A Retrospective Study of 151 Patients. CL LYMPH MYELOM LEUK 23 435-436. 1 sep 2023. . . F.I.:2,700 
Gomez-Vecino, A, Corchado-Cobos, R, Blanco-Gomez, A, Garcia-Sancha, N, Castillo-Lluva, S, Martin-Garcia, A, Mendiburu-Elicabe, M, Prieto, C, Ruiz-Pinto, S, Pita, G, Velasco-Ruiz, A, Patino-Alonso, C, Galindo-Villardon, P, Vera-Pedrosa, ML, Jalife, J, Mao, JH, de Plasencia, GM, Castellanos-Martin, A, Saez-Freire, MD, Fraile-Martin, S, Rodrigues-Teixeira, T, Garcia-Macias, C, Galvis-Jimenez, JM, Garcia-Sanchez, A, Isidoro-Garcia, M, Fuentes, M, Garcia-Cenador, MB, Garcia-Criado, FJ, Garcia-Hernandez, JL, Hernandez-Garcia, MA, Cruz-Hernandez, JJ, Rodriguez-Sanchez, CA, Garcia-Sancho, AM, Perez-Lopez, E, Perez-Martinez, A, Gutierrez-Larraya, F, Carton, AJ, Garcia-Saenz, JA, Patino-Garcia, A, Martin, M, Alonso-Gordoa, T, Vulsteke, C, Croes, L, Hatse, S, Van Brussel, T, Lambrechts, D, Wildiers, H, Chang, H, Holgado-Madruga, M, Gonzalez-Neira, A, Sanchez, PL, Losada, JP. Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk. CELLS-BASEL 12 -. 1 ago 2023. . . F.I.:6,000 [doi:10.3390/cells12151956]

Garcia-Sancho, AM, Baile, M, Rodriguez, G, Dlouhy, I, Sancho, JM, Jarque, I, Gonzalez-Barca, E, Salar, A, Espeso, M, Grande, C, Bergua, J, Montes-Moreno, S, Redondo, A, Enjuanes, A, Campo, E, Lopez-Guillermo, A, Caballero, D. Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: A phase 2 study from GELTAMO. BRIT J HAEMATOL 203 202-211. 23 jul 2023. 1 jul 2023. . F.I.:6,500 [doi:10.1111/bjh.18989]
Garcia-Sancho, AM, Rodriguez-Pinilla, SM, Domingo-Domenech, E, Climent, F, Sanchez-Garcia, J, Jimenez, JL, Piqueras, MGC, Castellvi, J, Gonzalez, AJ, de Villambrosia, SG, Codina, JG, Navarro, B, Rodriguez, G, Borrero, JJ, Fraga, M, Naves, A, Baeza, L, Cordoba, R. Peripheral T-cell lymphoma with a T follicular-helper phenotype: A different entity? Results of the Spanish Real-T study. BRIT J HAEMATOL 203 182-193. 30 jun 2023. 1 jun 2023. . F.I.:6,500 [doi:10.1111/bjh.18941]

Jimenez-Ubieto, A, Martin-Munoz, A, Poza, M, Dorado, S, Garcia-Ortiz, A, Revilla, E, Sarandeses, P, Ruiz-Heredia, Y, Baumann, T, Rodriguez, A, Calbacho, M, Sanchez, PM, Pina, JMS, Garcia-Sancho, AM, Figaredo, G, Rufian, L, Rodriguez, M, Carneros, L, Martinez-Laperche, C, Bastos-Oreiro, M, Wang, CW, Cedena, MT, Rapado, I, de Toledo, P, Valeri, A, Ayala, R, Martinez-Lopez, J, Barrio, S. Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients. FRONT IMMUNOL 14 -. 5 jun 2023. . . F.I.:7,300 [doi:10.3389/fimmu.2023.1188818]

Drescher, Charles, Walter, Harriet S., Gastinne, Thomas, Lakhani, Nehal J., Ribrag, Vincent, Rasco, Drew W., Gutierrez, Martin, Sullivan, Ryan J., Harvey, R. Donald, Banda, Kalyan, Kwiatek, Michal, Garcia-Sancho, Alejandro Martin, Duska, Linda R., Zinzani, Pier Luigi, Thakur, Anjali, Kann, Lennart, Faulhaber, Nicola, Jauch-Lembach, Julia, Kindler, Hedy L.. EZH2/EZH1 inhibitor tulmimetostat (CPI-0209) in patients with advanced solid tumors or hematologic malignancies: Preliminary phase II results.. J CLIN ONCOL 41 -. 1 jun 2023. . . F.I.:45,400 
Barca, EG, Tomas-Roca, L, Esteve, A, Rodriguez, M, Gato, L, Alonso-Alonso, R, Garcia-Sancho, AM, Cordoba, R, Monter-Rovira, A, Bastos-Oreiro, M, Burgues, JMB, Sayas, MJ, Alegria, MCV, Sanchez-Blanco, JJ, Pellicer, MR, Henriquez, HDL, de Ona, R, Cabezudo, ME, Infante, MS, Hernandez, JAQ, Sanz-Pamplona, R, Blanco, O, Mozos, A, Climent, F, Piris, MA. Extranodal natural killer/T-cell lymphoma nasal type in a western population: Molecular profiling identifies new therapeutic targets. AM J HEMATOL 98 134-138. 16 mar 2023. 1 mar 2023. . F.I.:12,800 [doi:10.1002/ajh.26904]